成人免费xx,国产又黄又湿又刺激不卡网站,成人性视频app菠萝网站,色天天天天

ChemicalBook--->CAS DataBase List--->2304558-24-3

2304558-24-3

2304558-24-3 Structure

2304558-24-3 Structure
IdentificationBack Directory
[Name]

TAMRA-PEG2-Maleimide
[CAS]

2304558-24-3
[Synonyms]

TAMRA-PEG2-Maleimide
[Molecular Formula]

C35H36N4O8
[MDL Number]

MFCD31811449
[MOL File]

2304558-24-3.mol
[Molecular Weight]

640.68
Hazard InformationBack Directory
[Description]

TAMRA-PEG2-Maleimide is a TAMRA red-fluorescent dye linker, with excitation/emission maximum 553/575 nm, containing a maleimide group which will react with a thiol group to form a covalent bond, enabling the connection of biomolecule with a thiol.
2304558-24-3 suppliers list
Company Name: Jilin Chinese Academy of Sciences-yanshen Technology
Tel: +undefined18143011203 , +undefined18143011203
Website: www.chemextension.com/
Company Name: Jinan Ruisi Pharmaceutical Technology Co., LTD  
Tel: 0531-69900633 18340090523
Website: http://www.is0513.com/ShowSupplierProductsList31265/0.htm
Company Name: Nanjing Shizhou Biology Technology Co.,Ltd  
Tel: 025-85563444 18351873721
Website: http://www.synzest.com
Company Name: Jilin Chinese Academy of Sciences - Yanshen Technology Co., Ltd  
Tel: 0431-80514535 19917294565
Website: www.chemextension.com
Company Name: Vicbio Biotechnology Co., Ltd.  
Tel: 13691409741
Website: www.vicbio.com/
Company Name: Shanghai Easy CDMO Co.,Ltd  
Tel: 021-61734564
Website:
Company Name: Jilin Chinese Academy of Sciences-yanshen Technology  
Tel: 18143011203
Website: www.chemextension.com/
Tags:2304558-24-3 Related Product Information
This site uses cookies
This website uses cookies and similar technologies to store and retrieve information about your use of this website. This information helps us to provide, analyse and improve our services, which may include personalised content or advertising. We may share this information with Google and other third parties. This cookies are necessary for our website to work properly . By clicking "Continue" or continuing to browse our site you are agreeing to our and our partners use of cookies.
Accept